haemonetics.com - HAE Total Company Value-to-Revenue Ratio

Haemonetics Corp (HAE) - corporate logo

Workshop modernization and assembly automation ensure stable product output, as confirmed by the linear chart from the GURU.Markets terminal. The enterprise value-to-annual revenue multiple remains at 4589.21. Growth is driven by the sale of high-margin consumables for affordable installations, while its status as a technological leader allows Haemonetics Corporation (HAE) to independently determine market prices for unique equipment.

Haemonetics Corp. (HAE) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for Haemonetics Corp. (HAE)

- share price and consensus valuation forecast:
Fundamental company valuation:HAE, haemonetics.com
Flagship merchandise of Haemonetics Corp

This indicator compares the total enterprise value, including net debt, to the volume of generated sales, reflecting the actual market price of one dollar of revenue. For Haemonetics Corporation (HAE), with its closed ecosystem of consumables and software, this enterprise value-to-revenue multiple highlights a premium valuation driven by high switching costs for customers.

Competitor analysis

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|INSP (Inspire Medical Systems Inc) - EV/Sales Multiple|PROCEPT BioRobotics Inc (PRCT) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple CNMD|Company Value to Revenue Pulse Biosciences, Inc. PLSE|EV/Sales Multiple INMD (inmodemd.com)|Picard Medical Inc. - Enterprise Value-to-Revenue Ratio|SRDX - Enterprise Value-to-Revenue Ratio|SENS: Enterprise Value-to-Revenue Ratio|NPCE (NeuroPace, Inc.) - Company Value to Revenue|Tactile Systems Technology, Inc. - Business Value to Revenue|SNWV (SANUWAVE Health Inc) - EV/Sales Multiple|EV/Sales Multiple Outset Medical|Enterprise Value-to-Revenue Ratio Electromed (ELMD)|LENSAR, Inc. (LNSR) - Enterprise Value-to-Sales Ratio|AVITA Medical Inc - Company Value to Revenue|EV/Sales Multiple Profound Medical Corporation PROF|Baird Medical Investment Holdings - EV/Sales Multiple|Total Company Value-to-Revenue Ratio EDAP TMS EDAP|Apyx Medical Corporation (APYX) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume ICCM (IceCure Medical, Ltd.)|Enterprise Value-to-Revenue Ratio pulmonx.com|Company Value to Revenue TELA Bio, Inc. (TELA)|EV/Sales Multiple CTSO|SRTS - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Zynex, Inc. ZYXI|ECOR: Company Value to Revenue Ratio|RBOT: Company Value to Revenue|inspira-technologies.com - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)